Coated balloons for blood vessel stabilization
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61L-029/08
A61K-047/32
A61K-031/11
A61K-031/7024
A61L-029/06
A61L-029/14
A61L-029/16
A61M-025/10
출원번호
US-0474342
(2012-05-17)
등록번호
US-9937255
(2018-04-10)
발명자
/ 주소
Ogle, Matthew F.
Carlyle, Wenda C.
Anderson, Edward J.
Udipi, Kishore
출원인 / 주소
NECTERO MEDICAL, INC.
대리인 / 주소
Knobbe Martens Olson & Bear LLP
인용정보
피인용 횟수 :
0인용 특허 :
75
초록▼
A coated balloon device for stabilizing a section of a blood vessel in a living subject is disclosed. The coating layer of the coated balloon comprises a phenolic compound having a plurality of phenolic groups connected to form a hydrophobic core with peripheral phenolic hydroxyl groups. The coating
A coated balloon device for stabilizing a section of a blood vessel in a living subject is disclosed. The coating layer of the coated balloon comprises a phenolic compound having a plurality of phenolic groups connected to form a hydrophobic core with peripheral phenolic hydroxyl groups. The coating layer of the coated balloon may contain a hydrophilic polymer to facilitate the release of the phenolic compound. The balloon in general is made of a compliant polymer for atraumatic contact with the blood vessel. In some embodiments, the coating of the coated balloon device further comprises a hydrophilic undercoat layer between the balloon and the coating layer. In some embodiments, the coated balloon device further comprises a sacrificial top coating that dissolves upon delivery into the section of the blood vessel and comprises a hydrophilic composition including sugar, sugar derivatives, or a combination thereof.
대표청구항▼
1. A coated balloon device for stabilizing a section of a blood vessel in a living subject comprising, a shaft having a proximal end and a distal end,a balloon element comprising an extendable structure having an outer surface, the balloon element being supported by the shaft at or near the distal e
1. A coated balloon device for stabilizing a section of a blood vessel in a living subject comprising, a shaft having a proximal end and a distal end,a balloon element comprising an extendable structure having an outer surface, the balloon element being supported by the shaft at or near the distal end of the shaft, wherein the extendable structure of the balloon element comprises a compliant polymer,a coating layer associated with the outer surface of the extendable structure, anda hydrophilic undercoat layer between the balloon element and the coating layer,wherein at least 5% by weight of the coating layer comprises a therapeutic composition that comprises a phenolic composition comprising tannic acid or an analog of tannic acid, pentagalloylglucose or an analog of pentagalloylglucose, a combination thereof, or a pharmaceutically acceptable salt thereof, andwherein the extendable structure of the balloon element comprises an unextended configuration, an inflated but un-expanded configuration and an expanded configuration. 2. The coated balloon device of claim 1 wherein the therapeutic composition has little or no unbound gallic acid. 3. The coated balloon device of claim 1 wherein the phenolic compound comprises pentagalloylglucose. 4. The coated balloon device of claim 1 wherein at least 50% by weight of the coating layer comprises the phenolic compound. 5. The coated balloon device of claim 1 wherein the coating layer have a thickness from about 20 microns to about 50 microns. 6. The coated balloon device of claim 1 wherein the therapeutic composition further comprises glutaraldehyde. 7. The coated balloon device of claim 1 wherein the coating layer further comprises a hydrophilic polymer. 8. The coated balloon device of claim 7 wherein the hydrophilic polymer comprises polyvinyl alcohol, polyvinyl pyrrolidone, polyethylene glycol, poly(lactic-co-glycolic acid), or a combination thereof. 9. The coated balloon device of claim 7 wherein the hydrophilic polymer comprises polysaccharide, dextran, starch, hyaluronic acid, collagen, gelatin, chitin, albumin, alginate, as such or as a derivative or a combination thereof. 10. The coated balloon device of claim 1 wherein the inflated but unexpanded configuration has a generally cylindrical section along the outer surface. 11. The coated balloon device of claim 1 wherein the extendable structure of the balloon element is a low durometer polyurethane balloon material. 12. The coated balloon device of claim 1 wherein the shaft comprises a balloon lumen having a distal opening into the interior of the balloon element and a proximal connection connected to a fluid source. 13. The coated balloon device of claim 1 further comprising a by-pass channel with an opening proximal to the balloon element and an opening distal to the balloon element that provides flow past the balloon when expanded in a vessel. 14. The coated balloon device of claim 1 wherein the undercoat layer has a thickness of from about 5 micron to about 50 microns. 15. The coated balloon device of claim 1 wherein the thickness ratio between the coating layer and the undercoat layer is from about 1:1, to about 10:1. 16. The coated balloon device of claim 1 wherein the undercoat layer is crosslinked to the balloon element. 17. The coated balloon device of claim 1 wherein the undercoat layer is porous to allow further hydration of the coating layer. 18. The coated balloon device of claim 1 further comprising a sheath slidably positioned over the shaft having a configuration extended in a distal direction relative to the shaft covering the extendable structure in the unextended configuration. 19. The coated balloon device of claim 1 further comprising a sacrificial top coating that dissolves upon delivery into the section of the blood vessel and comprises a hydrophilic composition. 20. The coated balloon device of claim 19 wherein the hydrophilic composition of the top coating is sugar, sugar derivatives, or a combination thereof. 21. The coated balloon device of claim 19 wherein the top coating has a thickness of from about 5 micron to about 50 microns. 22. The coated balloon device of claim 19 wherein the thickness ratio between the undercoat layer, the coating layer, and the top coating is from about 30:40:30 to about 10:85:5. 23. A coated balloon device for stabilizing a section of a blood vessel in a living subject comprising, a shaft having a distal end and a proximal end,a balloon element comprising an extendable structure having an outer surface, the balloon element being supported by the shaft at or near the distal end of the shaft, wherein the extendable structure comprise a compliant polymer,a coating associated with the outer surface of the extendable structure, anda hydrophilic undercoat layer between the balloon element and the coating,wherein the coating comprises a hydrophilic polymer binder and a therapeutic composition blended with the hydrophilic polymer, the therapeutic composition comprising a phenolic composition comprising tannic acid or an analog of tannic acid, pentagalloylglucose or an analog of pentagalloylglucose, a combination thereof, or a pharmaceutically acceptable salt thereof. 24. The coated balloon of claim 23 wherein the hydrophilic polymer comprises polyvinyl alcohol, polyvinyl pyrrolidone, polyethylene glycol, poly(lactic-co-glycolic acid), or a combination thereof. 25. The coated balloon device of claim 23 wherein the hydrophilic polymer comprises polysaccharide, dextran, starch, hyaluronic acid, collagen, gelatin, chitin, albumin, alginate, as such or as a derivative or a combination thereof. 26. The coated balloon of claim 23 wherein the phenolic composition is pentagalloylglucose. 27. The coated balloon of claim 23 wherein at least 25% by weight of the coating comprises the phenolic compound. 28. The coated balloon of claim 23 wherein the coating layer have a thickness from about 20 microns to about 50 microns. 29. The coated balloon of claim 23 wherein the therapeutic composition further comprises glutaraldehyde. 30. The coated balloon of claim 23 further comprising a by-pass channel with an opening proximal to the balloon element and an opening distal to the balloon element that provides flow past the balloon when expanded in a vessel.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (75)
French Brent A. ; Raizner Albert E. ; Roberts Robert, Adenoviral vector for inhibiting restenosis.
Lee Hye-Jung ; Johnson OluFunmi L. ; Zale Stephen E. ; Tracy Mark A., Composition and method using solid-phase particles for sustained in vivo release of a biologically active agent.
Guthrie Najla,CAX ; Kurowska Elzbieta Maria,CAX, Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols.
Kenneth B Kirby ; Berno I. R. Pettersson, Jr., Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof.
Kirby, Kenneth B; Pettersson, Berno, Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof.
Della Valle Francesco,ITX ; Lorenzi Silvana,ITX ; Cerini Roberto,ITX ; Marcolongo Gabriele,ITX, Highly bioadhesive and mucoadhesive compositions containing polyvinyl alcohol, polycarbophil and biopolymer for the tre.
Chapman, Harold A.; Shi, Guo-Ping; Libby, Peter; Sukhova, Galina K.; Simon, Daniel I., Methods of treating vascular disease associated with cystatin C deficiency.
Conway Anthony J. (Chatfield MN) Conway Philip J. (Chatfield MN) Fryar ; Jr. Richard D. (Rochester MN), Microcidal agent releasing catheter with balloon.
Semple, Joseph Edward; Weinhouse, Michael I.; Levy, Odile Esther; Madison, Edwin L.; Tamiz, Amir P., Non-covalent inhibitors of urokinase and blood vessel formation.
Diot Michel (2 alle des Dimanches Louveciennes FRX 78430) Bonne Claude (316 avenue d\Occitanie Montpellier FRX 34000), Novel cosmetic compositions containing an extract of the aerial parts of Cichorium intybus L.
Kohn, Joachim; Kemnitzer, III, John E.; Poiani, George J.; Riley, David J., Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor.
Poiani George J. ; Riley David J. ; Liao Wei-Chi ; Kahn Joachim ; Gean Keria Fiorella, Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use.
Varma, Ashish; Chaffin, Kimberly A.; Bates, Frank; Hillmyer, Marc; Lim, Lisa, Process for producing a hyper-elastic, high strength dilatation balloon made from multi-block copolymers.
Zuccato Alessandro,ITX ; Cella Gian Domenico,ITX ; Perego Gabriele,ITX, Process of surface activation of biocompatible and bioabsorbable aliphatic polyesters and polyesters thus activated.
Myers David J. (Camp Verde AZ) Lewis James D. (Flagstaff AZ) Campbell Carey V. (Flagstaff AZ), Prosthetic vascular graft with deflectably secured fibers.
Boersma,Christine J. C.; Van Der Saag,Paulus Theodorus Maria; Wissink,Sacha; Van Der Burg,Bart, Synergistic activation of regulatory elements by Rel proteins and a steroid receptor.
Mazzocchi, Rudy A.; Miller, Thomas I.; Parmer, Kari; Parmer, Timothy Alan; Solar, Matthew S., System and method of minimally-invasive exovascular aneurysm treatment.
Gombotz Wayne R. (Lexington MA) Healy Michael S. (E. Bridgewater MA) Brown Larry R. (Newton MA), Very low temperature casting of controlled release microspheres.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.